KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cvs Health (CVS) Short-Term Debt issuances (2016 - 2025)

Cvs Health's Short-Term Debt issuances history spans 16 years, with the latest figure at $872.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Short-Term Debt issuances rose 245.33% year-over-year to $872.0 million, compared with a TTM value of -$1.5 billion through Sep 2025, down 345.33%, and an annual FY2023 reading of $5.0 billion, changed N/A over the prior year.
  • Short-Term Debt issuances for Q4 2025 was $872.0 million at Cvs Health, up from -$1.8 billion in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $5.0 billion in Q2 2023, with the low at -$2.7 billion in Q2 2024.
  • Average Short-Term Debt issuances over 4 years is $525.2 million, with a median of $526.0 million recorded in 2021.
  • Biggest YoY gain for Short-Term Debt issuances was 245.33% in 2025; the steepest drop was 324.12% in 2025.
  • Tracing CVS's Short-Term Debt issuances over 4 years: stood at $252.0 million in 2021, then surged by 1884.13% to $5.0 billion in 2023, then tumbled by 112.0% to -$600.0 million in 2024, then surged by 245.33% to $872.0 million in 2025.
  • Per Business Quant, the three most recent readings for CVS's Short-Term Debt issuances are $872.0 million (Q4 2025), -$1.8 billion (Q3 2025), and $1.8 billion (Q2 2025).